Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Operating Expenses | 31 | 35 | 53 | 36 | 37 |
| Operating Income | -31 | -35 | -53 | -36 | -37 |
| Other Income | 1 | 2 | 3 | 4 | 5 |
| Pre-tax Income | -30 | -33 | -50 | -32 | -32 |
| Net Income Continuous | -30 | -33 | -50 | -32 | -32 |
| Net Income | $-30 | $-33 | $-50 | $-32 | $-32 |
| EPS Basic Total Ops | -1.00 | -1.00 | -2.00 | -1.00 | -1.00 |
| EPS Basic Continuous Ops | -1.02 | -1.11 | -1.70 | -1.10 | -1.10 |
| EPS Diluted Total Ops | -1.00 | -1.00 | -2.00 | -1.00 | -1.00 |
| EPS Diluted Continuous Ops | -1.02 | -1.11 | -1.70 | -1.10 | -1.10 |
| EBITDA(a) | $-31 | $-35 | $-53 | $-36 | $-37 |